High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention

scientific article published in January 2010

High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JCIN.2009.10.024
P698PubMed publication ID20129566
P5875ResearchGate publication ID41404501

P50authorFabio MangiacapraQ40625497
Emanuele BarbatoQ42844569
Germano Di SciascioQ59188165
William WijnsQ61278410
Catalina TranaQ87635928
Guy R HeyndrickxQ90553844
Olivier MullerQ102144464
Bernard De BruyneQ114304193
Jozef BartunekQ114309811
Argyrios NtalianisQ114411817
P433issue1
P921main subjectatherosclerosisQ12252367
myocardial infarctionQ12152
clopidogrelQ410237
stable anginaQ3617336
P304page(s)35-40
P577publication date2010-01-01
P1433published inJACC: Cardiovascular InterventionsQ15816248
P1476titleHigh residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention
P478volume3

Reverse relations

cites work (P2860)
Q37989558A contemporary viewpoint on 'aspirin resistance'.
Q36371663Adenosine A2A receptor agonists with potent antiplatelet activity.
Q38070127Clinical implications of platelet-vessel interaction
Q33760816Correlations between High Platelet Reactivity, Extent of Coronary Artery Disease, and Periprocedural Myonecrosis in Patients with Acute Coronary Syndrome
Q37605071Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients
Q54722997Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial.
Q50085829Effect of Chewing vs Swallowing Ticagrelor on Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.
Q30450312High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study
Q37203987Impact of Cytochrome P450 2C19*2 and *3 on Clopidogrel Loading Dose in Saudi Patients with Acute Coronary Syndrome
Q49948271Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysis
Q38071262Influence of platelet reactivity on clinical outcome of patients with stable coronary artery disease.
Q46211908Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel
Q38073160Novel antiplatelet agents: ALX-0081, a Nanobody directed towards von Willebrand factor
Q61651390Optimizing Revascularization Strategies in Coronary Artery Disease for Optimal Benefit to Patients
Q51594125PREDICT score and CYP2C19 polymorphism independently predict lack of efficacy of clopidogrel in cardiology patients.
Q57097673Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention
Q39433616Platelet oxidative stress as a novel target of cardiovascular risk in frail older people.
Q37765291Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoing percutaneous coronary revascularization
Q45710775St. John's Wort in patients non-responders to clopidogrel undergoing percutaneous coronary intervention: a single-center randomized open-label trial (St. John's Trial).
Q38375641Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2-Hour Infusion in High-Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
Q61651374von Willebrand Factor Inhibition Improves Endothelial Function in Patients with Stable Angina

Search more.